Published in Blood Weekly, January 13th, 2000
In 1998, Biomira, Inc., reported that potent primary anti-MUC1 T-cell responses could be generated in vitro following incubation of normal human antigen presenting cells (APCs) with BLP25 liposomes followed by the addition of autologous T cells to the culture.
More recent data presented at the Society for Biological Therapy Annual Meeting in Boston...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.